Thank you, John, and good afternoon, everyone. Revenue grew to $69 million, 5% year over year, reflecting strong demand from ...
In recent days, Recursion Pharmaceuticals announced a major leadership transition appointing Najat Khan, Ph.D., as CEO effective January 1, 2026, while also securing a milestone payment from Roche and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback